BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25900461)

  • 1. Bisphosphonate and risk of cancer recurrence: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.
    Liu Y; Du C; Zhang Y; Zhao S; Zhao L; Li P; Hu F; Zhu L; Liu Y; Pang D; Zhao Y
    BMJ Open; 2015 Apr; 5(4):e007215. PubMed ID: 25900461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
    Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carotid endarterectomy with primary closure versus patch angioplasty in patients with symptomatic and significant stenosis: protocol for a systematic review with meta-analyses and trial sequential analysis of randomised clinical trials.
    Marsman MS; Wetterslev J; Jahrome AK; Gluud C; Moll FL; Karimi A; Keus F; Koning GG
    BMJ Open; 2019 Apr; 9(4):e026419. PubMed ID: 30948603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
    Mauri D; Valachis A; Polyzos NP; Tsali L; Mavroudis D; Georgoulias V; Casazza G
    J Natl Compr Canc Netw; 2010 Mar; 8(3):279-86. PubMed ID: 20202461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel.
    Hadji P; Coleman RE; Wilson C; Powles TJ; Clézardin P; Aapro M; Costa L; Body JJ; Markopoulos C; Santini D; Diel I; Di Leo A; Cameron D; Dodwell D; Smith I; Gnant M; Gray R; Harbeck N; Thurlimann B; Untch M; Cortes J; Martin M; Albert US; Conte PF; Ejlertsen B; Bergh J; Kaufmann M; Holen I
    Ann Oncol; 2016 Mar; 27(3):379-90. PubMed ID: 26681681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis.
    Chu H; Jang BH; Kim G; Bae S; Lee H; Nam S; Ahn J
    BMJ Open; 2022 Sep; 12(9):e062537. PubMed ID: 36167395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transepithelial versus epithelium-off corneal collagen cross-linking for corneal ectasia: protocol for a systematic review, meta-analysis and trial sequential analysis of randomised controlled trials.
    Nath S; Shen C; Koziarz A; Banfield L; Fava MA; Hodge WG
    BMJ Open; 2019 May; 9(5):e025728. PubMed ID: 31133582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of neoadjuvant treatment in resectable pancreatic cancer: a systematic review and meta-analysis protocol.
    Lee JC; Ahn S; Paik KH; Kim HW; Kang J; Kim J; Hwang JH
    BMJ Open; 2016 Mar; 6(3):e010491. PubMed ID: 27016245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical benefits of bone targeted agents in early breast cancer.
    Coleman R
    Breast; 2019 Nov; 48 Suppl 1():S92-S96. PubMed ID: 31839171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonates in adjuvant setting for breast cancer: a review of the meta-analysis of bisphosphonates' effects on breast cancer recurrence presented in December 2013 at San Antonio Breast Conference.
    Costa L
    Curr Opin Support Palliat Care; 2014 Dec; 8(4):414-9. PubMed ID: 25319273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fever control interventions versus placebo, sham or no intervention in adults: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.
    Sethi N; Naqash AI; Nielsen N; Jakobsen JC
    BMJ Open; 2019 Nov; 9(11):e032389. PubMed ID: 31685514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and breast cancer survival: a meta-analysis and trial sequential analysis of 81508 participants from 23 prospective epidemiological studies.
    Liu Y; Zhao S; Zhang Y; Onwuka JU; Zhang Q; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19835-19866. PubMed ID: 34375305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of combination therapy in the treatment of primary osteoporosis: protocol for a network meta-analysis of randomised trials.
    Lou S; Lv H; Chen Y; Zhang L; Tang P
    BMJ Open; 2016 Nov; 6(11):e012802. PubMed ID: 28186942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimum duration of extended adjuvant endocrine therapy in patients with hormone receptor-positive breast cancer: protocol for a network meta-analysis of randomised controlled trials.
    Hu Q; Ye D; Xudong Z; Wang Q; Gou H; Luo T
    BMJ Open; 2023 Apr; 13(4):e070972. PubMed ID: 37080619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network meta-analysis of randomised trials of pharmacological, psychotherapeutic, exercise and collaborative care interventions for depressive symptoms in patients with coronary artery disease: hybrid systematic review of systematic reviews protocol.
    Doyle F; Freedland K; Carney R; de Jonge P; Dickens C; Pedersen S; Sorensen J; Dempster M
    Syst Rev; 2019 Mar; 8(1):71. PubMed ID: 30878039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate for spontaneous osteonecrosis of the knee: A protocol for systematic review and meta-analysis of randomized controlled trials.
    Shen Z; Chen Z; Xie Z; Xu Y; Wang T; Li J; Yuan C; Liu J; Shi X; Ai Y; Dong W; Guo Y
    Medicine (Baltimore); 2020 Dec; 99(49):e23123. PubMed ID: 33285686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.